Beta Alethine in Treating Patients With Low-Grade Lymphoma
NCT00007839
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
INDUSTRY
Sponsor class
Conditions
Lymphoma
Interventions
DRUG:
beta alethine
Sponsor
LifeTime Pharmaceuticals